Xufeng Lu

机构：Wenzhou Medical University, First Affiliated Hospital of Wenzhou Medical University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University · ORCID：0000-0002-4247-4955

发表论文 51 篇 · 总被引 512 次 · h-index 10

代表论文

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy (2024 · Advanced Science · 被引 155)
PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy (2024 · Materials Today Bio · 被引 29)
Machine Learning Radiomics Liver Function Model for Prognostic Prediction After Radical Resection of Advanced Gastric Cancer: A Retrospective Study (2023 · Annals of Surgical Oncology · 被引 13)
An Fe(III)-covalent organic framework (COF)–sorafenib nanoplatform induces chemo-ferroptosis for enhanced hepatocellular carcinoma immunotherapy (2025 · Materials Today Bio · 被引 9)
Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer (2025 · International Journal of Biological Macromolecules · 被引 8)
NOLC1 suppresses immunochemotherapy by inhibiting p53-mediated ferroptosis in gastric cancer (2025 · eLife · 被引 1)